BioPeptics Review
Rank #8 of 10
biopeptics.co.za vendor site ↗ (reference only, not an endorsement)
Evidence confidence: Medium. · Last verified: 2026-09-22
A vendor with a genuinely detailed shipping policy, real contact details, and an unusually thorough safety-conscious FAQ — offset by broken policy links and no named testing laboratory.
What we verified
We independently confirmed that biopeptics.co.za publishes a retatrutide 30mg product page priced at R2,600.00, with a repeated research-use-only disclaimer and references to third-party testing [27]. A direct browser-rendered re-check additionally confirmed a detailed Delivery Policy, real Contact-page details (phone, email, office hours), and a thorough FAQ page including a genuine safety-research warning about angiogenic peptides and cancer-model research. The same re-check found that the site's “Policies” navigation link and “Returns & Refunds” footer link both return a 404.
What the vendor claims
BioPeptics describes retatrutide as a “next-generation triple receptor agonist peptide” targeting GLP-1, GIP and glucagon pathways, and claims its products are “independently third-party tested for identity and purity verification”, “verified for >99% purity by independent analysis” [27]. Its About page states products are “supported by clear reconstitution and usage guidelines” without naming a specific laboratory.
Testing & documentation
No specific testing laboratory is named anywhere in the content reviewed, and no downloadable Certificate of Analysis document or report identifier was confirmed — only a generic “independent analysis” claim repeated across the homepage, About page and product pages. This is a generic testing claim rather than a checkable disclosure.
Business transparency
A direct re-check of the Contact page confirmed a phone number (061 542 2136), an email address (info@biopeptics.co.za), and stated office hours (Mon–Fri, 08:00–17:00). No physical address or business registration information was found anywhere on the site.
Shipping
BioPeptics' Delivery Policy is genuinely detailed: it names two courier partners (The Courier Guy and Aramex), states orders placed before noon are processed same-day, and gives a standard delivery window of 2–5 business days within South Africa. We confirmed this text is directly published; we did not independently test actual delivery performance.
Refunds & returns
The site's footer links to a “Returns & Refunds” page, but a direct re-check found this URL returns a 404 — the page does not currently resolve, despite being linked from the site's own footer on every page.
Website & policies
No privacy policy or terms-of-service page could be found anywhere in BioPeptics' navigation. The site's own “Policies” navigation link itself returns a 404 on direct re-check.
Public reputation
We could not locate a dedicated review-platform page for biopeptics.co.za. We are treating this as an absence of accessible evidence, not as a negative signal in itself.
Regulatory & research-use context
BioPeptics frames its products as for research use only and not intended to diagnose, treat, cure or prevent disease, consistent with retatrutide's investigational status generally (see our retatrutide research overview). Its FAQ page includes a substantive, genuinely science-literate safety-research warning about certain angiogenic peptides' potential relevance to cancer-model research — a more thorough safety disclosure than most vendors in this edition provide. No SAHPRA registration or approval is claimed.
Strengths & limitations
Strengths
- A clear, repeated “for research use only” disclaimer stating products are not intended to diagnose, treat, cure or prevent disease, backed by an unusually thorough FAQ that includes a genuine safety-research warning about angiogenic peptides and cancer-model research
- A detailed, substantive Delivery Policy naming two named courier partners (The Courier Guy, Aramex) with specific processing and delivery timeframes
- Real contact details confirmed on a direct re-check: a phone number, an email address, and stated office hours
Limitations
- The site's own “Policies” navigation link and its “Returns & Refunds” footer link both return a 404 error on direct re-check; no privacy policy or terms-of-service page could be found anywhere in the site's navigation
- No specific testing laboratory is named and no Certificate of Analysis document or identifier was confirmed — testing is described only as generic “independent analysis”
- No business address or registration information is published
- No independent public reputation signal (review platform) could be located for this vendor
Evidence confidence
Medium. A direct browser-rendered re-check found a detailed, substantive Delivery Policy and confirmed real contact details (phone, email, hours), plus an unusually thorough FAQ including a genuine safety-research warning about angiogenic peptides. It also found that the site's own “Policies” and “Returns & Refunds” links both 404, and no named testing laboratory or business registration was found anywhere.
Methodology score breakdown
| Criterion | Why this score | Points |
|---|---|---|
| Business Transparency | A direct re-check confirmed a phone number, an email address and stated office hours on the Contact page, but no address and no business registration number was found anywhere. | |
| Testing & Documentation Disclosure | A generic “independently third-party tested,” “>99% purity by independent analysis” claim is repeated across several pages, but no laboratory is named and no COA identifier is given. | |
| Independent Verifiability of Testing Claims | No named laboratory or identifier exists to independently verify. | |
| Policy Completeness (Shipping, Refunds, Terms, Privacy) | A Delivery Policy is published with genuine, specific detail, but the site's own “Returns & Refunds” footer link and “Policies” navigation link both return a 404 on direct re-check, and no privacy or terms page could be found anywhere in the navigation. | |
| Research-Use & Regulatory Framing Clarity | “For Research Use Only” appears repeatedly, with a dedicated FAQ explaining why, and an unusually substantive safety-research warning section about angiogenic peptides — among the more thorough research-use disclosures in this edition. | |
| Public Reputation Signals | No dedicated review-platform page was located for this vendor. | |
| Website & Policy Reliability | The site functions and most pages load correctly, but a direct re-check found two confirmed broken links (“Policies” and “Returns & Refunds” both 404) that are referenced directly in the site's own navigation and footer. | |
| Source Accessibility for Independent Review | All pages attempted in a direct re-check loaded (including the two that returned a 404, which is informative rather than a fetch failure). | |
| Total | 40 / 100 | |
Sources for this review
- [27]biopeptics.co.za — Retatrutide 30mg product page nofollow Accessed 2026-09-22
Editorial conclusion
The evidence supports BioPeptics as a vendor with a genuinely detailed shipping policy, real contact information, and an unusually thoughtful, safety-conscious FAQ — stronger disclosure in these specific areas than this review initially found. Set against that: two of its own policy links (Policies, Returns & Refunds) return a 404 on direct re-check, no testing laboratory is named, and no business address or registration is published. Those gaps are recorded as absence of evidence or confirmed inconsistency, not as an accusation. From a transparency standpoint, a reader would need to seek a working returns policy and independent testing confirmation from sources beyond the vendor's own site.